当前位置:首页 > 文献互助 > 互助详情

Ifebemtinib plus garsorasib as first-line treatment for KRASG12C-mutated non-small-cell lung cancer in China: a multicentre, single-arm expansion cohort from a phase 1b/2 trial复制

用户sar7Gc5emZOY 2小时前 14 10 已关闭

DOI: 10.1016/s2213-2600(26)00142-6复制

文献链接: https://linkinghub.elsevier.com/retrieve/pii/S2213260026001426复制

其他信息:

出版社: Elsevier BV
作者: Zhengbo Song; Xingya Li; Rongbo Lin; Huaqiu Shi; Yuan Yuan; Ying Liu; Yongzhong Luo; Tangfeng Lv; Yiping Zhang; Liming Zhu; Yinxin Zhu; Ling Zhang; Zaiqi Wang

互助时间线

2026-08-03 14:09:46 [关闭求助]

楼主用户sar7Gc5emZOY关闭了求助

2026-08-03 14:08:37 [发起求助]